Monastrol
CAS No. 329689-23-8
Monastrol ( ±)-Monastrol )
产品货号. M14088 CAS No. 329689-23-8
A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥446 | 有现货 |
|
5MG | ¥551 | 有现货 |
|
10MG | ¥753 | 有现货 |
|
25MG | ¥1539 | 有现货 |
|
50MG | ¥2592 | 有现货 |
|
100MG | ¥4625 | 有现货 |
|
500MG | ¥10125 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Monastrol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition).
-
产品描述A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition); does not inhibit microtubule motility driven by conventional kinesin at 200 uM; inhibits both the basal and the microtubule-stimulated ATPase activity of the Eg5 motor domain, does not compete with ATP binding to Eg5; arrests cells in mitosis with monoastral spindles, and (S)-monastrol is a more potent inhibitor of Eg5 activity in vitro and in vivo.
-
同义词±)-Monastrol
-
通路Cytoskeleton/Cell Adhesion Molecules
-
靶点Kinesin
-
受体Eg5
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number329689-23-8
-
分子量292.35
-
分子式C14H16N2O3S
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 33 mg/mL
-
SMILESCCOC(=O)C1=C(NC(=S)NC1C2=CC(=CC=C2)O)C
-
化学全称5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-4-(3-hydroxyphenyl)-6-methyl-2-thioxo-, ethyl ester
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Mayer TU, et al. Science. 1999 Oct 29;286(5441):971-4.
2. Kapoor TM, et al. J Cell Biol. 2000 Sep 4;150(5):975-88.
3. DeBonis S, et al. Biochemistry. 2003 Jan 21;42(2):338-49.
4. Maliga Z, et al. Chem Biol. 2002 Sep;9(9):989-96.
2. Kapoor TM, et al. J Cell Biol. 2000 Sep 4;150(5):975-88.
3. DeBonis S, et al. Biochemistry. 2003 Jan 21;42(2):338-49.
4. Maliga Z, et al. Chem Biol. 2002 Sep;9(9):989-96.
产品手册
关联产品
-
BRD 9876
BRD 9876 is an ATP- and ADP-competitive Eg5 (kinesin-5) inhibitor with Ki of 4 nM.
-
TCS-OX2-29
TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold selectivity for OX2 over OX1.
-
KSP-IA
A potent, specific, allosteric and cell-active inhibitor of KSP with IC50 of 11 nM; has no ihibitory activity toward other kinesins.